GSK’s Bird Flu Vaccine Approval May Hinge On Pandemic Postmarketing Study
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will ask its Vaccines and Related Biological Products Advisory Committee to talk about how to verify and describe the clinical benefit of the vaccine under the accelerated approval regulations.